R

Roivant Sciences

Biopharmaceutical company developing RNA therapeutics

Associate

Corporate StrategyConfirmed live in the last 24 hours
Full-timeNew York, NY, USAIn-person

About the Job

Requirements

  • Candidates should have at least two years of relevant full-time work experience.
  • Candidates should have an exceptional academic background.
  • Candidates should have an entrepreneurial mindset and a strong desire to operate in a fast-paced environment.
  • Candidates should demonstrate intellectual curiosity and the ability to navigate ambiguity.
  • Candidates should have strong analytical and problem-solving skills and the ability to execute at a high velocity.
  • Candidates should have excellent communication skills and be capable of engaging with executives and stakeholders.
  • Candidates should have experience in venture building or product development, whether at a startup, within a larger organization, or in an incubation setting; healthcare or life sciences technology experience is ideal.

Responsibilities

  • Support early-stage ideation by identifying and evaluating potential opportunities based on time to market, Roivant’s strategic advantages, validation pathway, and market potential.
  • Develop and execute structured workplans to assess incubation opportunities, conducting quantitative and qualitative analyses of markets, competitors, product landscapes, and technology.
  • Assist in the initial stages of company building, contributing to product development, business development, operations, and fundraising.
  • Support leadership recruitment efforts by defining role profiles and sourcing candidates for new Vants.
  • Collaborate with incubated ventures, working directly with leadership teams during key business inflection points, such as fundraising or strategic pivots.

About the Company

Roivant Sciences

Biopharmaceutical company developing RNA therapeutics

Roivant Sciences develops and commercializes medicines through in-house programs and strategic partnerships, with a focus on genetic disorders and RNA therapeutics. Its Genevant subsidiary uses proprietary delivery platforms to create RNA-based treatments, including mRNA, RNA interference, and gene editing. Revenue comes from developing drug candidates, licensing and collaborations, and selling approved drugs. The goal is to bring effective therapies to patients more quickly by combining technology platforms with partner networks.

Company size
201-500
Company stage
IPO
Headquarters
New York City, New York
Founded
2014

Recently Posted Jobs

Explore more opportunities at Roivant Sciences

See more jobs